Skip to main content
. 2022 Oct 26;9(5):470–475. doi: 10.14744/nci.2021.90094

Table 3.

Demographic and laboratory data of the groups

Group-1 (n=352) Group-2 (n=104) p
Age 69.45±11.06 65.69±15.38 0.261
Gender (%) 0.789
Female 37.5 34.6
Male 72.5 65.4
BMI 24.2±2.75 23.8±2.56 0.856
GH (<1 ng/ml) 0.125±0.88 0.238±0.194 0.000
IGF-1(ng/ml) 55.05±23.3 104.08±31.46 0.000
AST (7–40 U/L) 23.83±9.14 23.03±12.89 0.715
ALT (7–40 U/L) 27.30±11.20 28.53±21.98 0.785
GFR 80.31±22.70 81.42±24.64 0.831
Creatinine (<1 mg/dl) 0.96±0.34 0.94±0.28 0.841
Glucose (70–100 mg/dl) 118.57±19.59 107.46±14.94 0.848
HBA1C (<6.5%) 6.75±1.46 6.24±0.80 0.880
CRP (<5 mg/L) 90.72±62.42 50.0±67.09 0.006
Hospital stay 8.80±2.14 4.75±1.25 0.002

BMI: Body mass index; GH: Growth hormone; IGF-I: Insulin-like growth factor-I; HbA1c: Glycosylated hemoglobin; ALT: Alanine amino transferase; AST: Aspartate amino transferase; BUN: Blood urea nitrogen; eGFR: Estimated glomerular filtration rate; CRP: C reactive protein.